Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Oberg

Showing results (41-50 of 302) with videos related to

Pageof 31
Sort By:
The British Journal of Surgery|February 15, 2000
Neuroendocrine tumours of the pancreasB Eriksson, K Oberg
Acta Endocrinologica|October 1, 1981
hCG and hCG subunits as tumour markers in patients with endocrine pancreatic tumours and carcinoidsK Oberg, L Wide
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Neuroendocrine bronchial and thymic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-upK Oberg, S Jelic,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2008
Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-upK Oberg, S Jelic,
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
The role of interferons in the management of carcinoid tumorsK Oberg, B Eriksson
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
An update of the medical treatment of malignant endocrine pancreatic tumorsB Eriksson, K Oberg
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-upK Oberg, S Jelic,
Advances in Experimental Medicine and Biology|February 24, 2001
Chromogranins as diagnostic and prognostic markers in neuroendocrine tumoursK Oberg, M Stridsberg
Applied Ergonomics|February 29, 2000
Maximum isometric trunk muscle strength and activity at trunk axial rotation during sittingA Torén, K Oberg
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumorsB Eriksson, K Oberg
Pageof 31

Showing results (41-50 of 302) with videos related to

Sort By:
Pageof 31
The British Journal of Surgery|February 15, 2000
Neuroendocrine tumours of the pancreasB Eriksson, K Oberg
Acta Endocrinologica|October 1, 1981
hCG and hCG subunits as tumour markers in patients with endocrine pancreatic tumours and carcinoidsK Oberg, L Wide
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Neuroendocrine bronchial and thymic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-upK Oberg, S Jelic,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2008
Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-upK Oberg, S Jelic,
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
The role of interferons in the management of carcinoid tumorsK Oberg, B Eriksson
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
An update of the medical treatment of malignant endocrine pancreatic tumorsB Eriksson, K Oberg
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-upK Oberg, S Jelic,
Advances in Experimental Medicine and Biology|February 24, 2001
Chromogranins as diagnostic and prognostic markers in neuroendocrine tumoursK Oberg, M Stridsberg
Applied Ergonomics|February 29, 2000
Maximum isometric trunk muscle strength and activity at trunk axial rotation during sittingA Torén, K Oberg
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumorsB Eriksson, K Oberg
Pageof 31